It is composed of 83 amino acids, with an additional 13 amino acids at the N-terminal end compared to regular IGF-1
Its defining property is receptor selectivity at typical research doses it produces minimal cortisol, prolactin, or ACTH elevation, distinguishing it from earlier GHRPs like GHRP-6 or GHRP-2
This might involve increased dosing (up to 1000-1500mg per injection), enhanced frequency (moving from once weekly to twice or three times weekly), or strategic combination with synergistic supplements to amplify glutathione's effects
Two structural changes drive the difference
Some may report decreased insulin sensitivity, increased insulin resistance, and high blood sugars due to altered cortisol levels
Our research shows a 35% decrease in oxidative stress markers